Synthesis, Crystal Structure and Antitumor Activity of (E)-1-(7-Methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(2-methoxyphenyl)-2-(1H-1,2,4-triazol-1-yl)propenol

Li Shui-Shi,Li Wan,Ye Jiao,Hu Ai-Xi
DOI: https://doi.org/10.14102/j.cnki.0254-5861.2011-1495
IF: 0.847
2017-01-01
Chinese journal of structural chemistry
Abstract:The title compound, (E)-1-(7-methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(2-methoxyphenyl)-2-(1H-1,2,4-triazol-1-yl) propenol (3a), was synthesized by the Aldol condensation reaction of 1-(7-methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-2-(1,2,4-triazol-1- yl) ethanone with 2-methoxybenzaldehyde and then reduced with NaBH4, and its crystal structure was determined by single-crystal X-ray diffraction: monoclinic system, space group P2(1) with a = 6.2002(3), b = 12.8452(7), c = 13.2257(7) angstrom, Z = 2, V = 1031.23(9) angstrom(3), M-r = 407.46, D-c = 1.312 Mg/m(3), S = 1.054, mu = 0.091 mm(-1), F(000) = 432, the final R = 0.0353 and wR = 0.0769 for 3161 observed reflections (I > 2 sigma(I)). X-ray analysis displays that the title compound adopts an E configuration for the C(7)= C(8) double bond and S configuration for the chirality center with the specific rotation of -63.75 degrees. Furthermore, the stability of the crystal was maintained through the intermolecular hydrogen bond O(1)-H center dot center dot center dot N(3). The antitumor assay exhibits that the title compound 3a (E configuration) has a good antitumor activity against the Hela cell line with the IC50 value of 36.9 mu M, which is better than that of 3b (Z configuration).
What problem does this paper attempt to address?